Lilly, Novo Sink on FDA List of Foreign GLP-1 Manufacturers (2)

Shares of Eli Lilly & Co. and Novo Nordisk A/S fell after US regulators established a “green list” of foreign manufacturers who produce raw materials that compounding pharmacies use to make copies of their blockbuster GLP-1 drugs.

The Food and Drug Administration said ina statementFriday that, in an effort to block the importation of potentially dangerous versions of the active ingredients used in drugs like Wegovy and Mounjaro, it would publish a list of overseas suppliers that appear to comply with the agency’s standards. Compounding pharmacies use these raw materials to make their own versions of the brand-name ...